IXICO PLC

IXI

Delayed - 11/25 11:35:14 am
123.5GBX	+4.22%

Prev.	118.5000
Open	118.5000
High	125.1999
Low	118.0400
Volume	98 055

02/19	IXICO : to Present AI Segmentation Research
02/10	IXICO : to Present at Innovation Forum
02/03	IXICO : Supports the AD Neuroimaging Initiative
12/02	IXICO : to Present at Alzheimer's Disease Congress

	Short Term	Mid-Term	Long Term
Trend	Bullish	Bullish	Bullish
Resistance	119	124	154
Spread/Res.	3,8%	-0,40%	-20%
Spread/Supp.	24%	39%	67%
Support	100	89,0	74,0

Sales 2020	9,32 M 12,5 M 12,5 M
Net income 2020	0,70 M 0,94 M 0,94 M
Net cash 2020	7,65 M 10,2 M 10,2 M
P/E ratio 2020	79,0x
Yield 2020	-

Capitalization	55,8 M 74,5 M 74,6 M
EV / Sales 2020	5,17x
EV / Sales 2021	4,95x
Nbr of Employees	68
Free-Float	60,9%

IXICO plc is a brain health company. The Company's brain health focus includes Alzheimer's disease, Huntington's disease, Parkinson's disease, behavioral health and adolescent mental health. It is a provider of clinical trials services to pharmaceutical companies. Its products include Assessa,...

>> Read more

Sector :

Biotechnology & Medical Research - NEC

Calendar :

2020-12-02 Earnings Release

Trading Rating :

Investor Rating :

Mean consensus	BUY
Number of Analysts	2
Average target price	117,00 GBX
Last Close Price	118,50 GBX
Spread / Highest target	-1,27%
Spread / Average Target	-1,27%
Spread / Lowest Target	-1,27%